My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Wipro climbs up after reporting good Q4 results
Apr 26,2017

The result was announced after market hours yesterday, 25 April 2017. The result was announced as per International Financial Reporting Standards.

Meanwhile, the S&P BSE Sensex was up 104.09 points, or 0.35%, to 30,047.33.

On the BSE, so far 2.95 lakh shares were traded in the counter, compared with average daily volumes of 4.3 lakh shares in the past one quarter. The stock had hit a high of Rs 513 and a low of Rs 497.50 so far during the day. The stock had hit a 52-week high of Rs 577.50 on 13 July 2016. The stock had hit a 52-week low of Rs 410 on 9 November 2016.

Abidali Z. Neemuchwala, Chief Executive Officer and Member of the Board, said that the company is confident that the recovery in energy and utilities and demonstrated strength in digital will help improve growth trajectory during the course of the current financial year.

In its outlook, Wipro expects revenues from its IT services business to be in the range of $1915 million to $1955 million for the Q1 June 2017.

The board recommended 1:1 bonus issue.

Wipro is a leading information technology, consulting and business process services company that delivers solutions to enable its clients do business better.

Powered by Capital Market - Live News

Brokerage buy boosts UltraTech Cement
Apr 25,2017

Meanwhile, the S&P BSE Sensex was up 290.20 points or 0.98% at 29,946.04.

On the BSE, 30,000 shares were traded on the counter so far as against the average daily volumes of 25,253 shares in the past one quarter. The stock had hit a high of Rs 4,259.90 so far during the day, which is a record high. The stock hit a low of Rs 4,110.05 so far during the day.

The stock had hit a 52-week low of Rs 3,050 on 11 May 2016. It had outperformed the market over the past one month till 24 April 2017, advancing 4.34% compared with the Sensexs 0.8% rise. The scrip had also outperformed the market over the past one quarter, gaining 13.47% as against the Sensexs 8.33% rise.

The large-cap company has equity capital of Rs 274.51 crore. Face value per share is Rs 10.

Shares of UltraTech Cement had risen 4.42% to settle at Rs 4,144. 35 yesterday, 24 April 2017. The companys consolidated net profit declined 11.24% to Rs 726 crore on 2.59% growth in net sales to Rs 6922 crore in Q4 March 2017 over Q4 March 2016. The result was announced during market hours yesterday, 24 April 2017.

UltraTech said that work on setting up the 3.5 million tonnes per annum (MTPA) integrated cement plant at Dhar, Madhya Pradesh is on track. Commercial production is expected to commence from Q4 of FY 2019.

With this expansion and the acquisition of the cement plants of Jaiprakash Associates, the companys cement capacity will stand augmented to 95.4 MTPA, including its overseas operations.

UltraTech Cement is a leading cement manufacturer in India. It is a part of the Aditya Birla Group.

Powered by Capital Market - Live News

Can Fin Homes moves up on strong Q4 results
Apr 25,2017

The result was announced during market hours today, 25 April 2017.

The stock has jumped 7.81% in five sessions to its ruling price of Rs 2,625.80, from a close of Rs 2,435.55 on 19 April 2017.

Meanwhile, the S&P BSE Sensex was up 252.62 points, or 0.85%, to 29,908.46. The S&P BSE Mid-Cap index was up 134.70 points, or 0.92%, to 14,760.43.

On the BSE, 16,089 shares were traded in the counter so far, compared with an average volume of 11,143 shares in the past one quarter.

The stock had hit a high of Rs 2,633.95 and a low of Rs 2,555.25 so far during the day. The stock had hit a record high of Rs 2,669.55 on 13 April 2017. The stock had hit a 52-week low of Rs 1,079.85 on 24 June 2016.

It had outperformed the market over the past one month till 24 April 2017, gaining 25.03% compared with the Sensexs 0.8% rise. The scrip had also outperformed the market over the past one quarter, advancing 49.28% as against the Sensexs 8.33% rise.

The mid-cap company has an equity capital of Rs 26.62 crore. Face value per share is Rs 10.

Can Fin Homes main business is to provide loans for the purchase and construction of residential houses.

Powered by Capital Market - Live News

M&M moves north on brokerage rating
Apr 25,2017

Meanwhile, the S&P BSE Sensex was up 255.32 points or 0.86% at 29,911.16.

On the BSE, 15.34 lakh shares were traded on the counter so far as against the average daily volumes of 1.46 lakh shares in the past one quarter. The stock had hit a high of Rs 1,310 and a low of Rs 1,279.05 so far during the day.

The stock had hit a record high of Rs 1,508.80 on 9 August 2016 and a 52-week low of Rs 1,141.80 on 2 December 2016. It had underperformed the market over the past one month till 24 April 2017, sliding 0.9% compared with the Sensexs 0.8% rise. The scrip had also underperformed the market over the past one quarter, gaining 3.65% as against the Sensexs 8.33% rise.

As per reports, the brokerage has upgraded Mahindra & Mahindra (M&M) stock to outperform from neutral with increased target price at Rs 1,500 from Rs 1,390 earlier. The brokerage house cited potential for M&Ms tractor business that will surprise positively going ahead.

Reports suggested that the brokerage believes with number of state governments planning to introduce farm loan waivers, tractor demand could get further boost. The brokerage added that weakness in utility vehicle market already factored in by M&M.

M&Ms net profit rose 33.3% to Rs 1112.27 crore on 0.3% decline in net sales to Rs 10860.05 crore in Q3 December 2016 over Q3 December 2015.

M&M enjoys a leadership position in tractors and utility vehicles in India.

Powered by Capital Market - Live News

Alembic Pharma rises after USFDA approvals for drugs
Apr 25,2017

The announcement was made during market hours today, 25 April 2017.

Meanwhile, the S&P BSE Sensex was up 241.56 points, or 0.81% to 29,897.40.

On the BSE, 12,483 shares were traded in the counter so far, compared with average daily volumes of 59,265 shares in the past one quarter. The stock had hit a high of Rs 629 and a low of Rs 605 so far during the day.

The stock had hit a 52-week high of Rs 709.30 on 23 March 2017. The stock had hit a 52-week low of Rs 517.90 on 24 June 2016.

It had underperformed the market over the past one month till 24 April 2017, gaining 0.51% compared with the Sensexs 0.8% rise. The scrip had also under performed the market over the past one quarter, advancing 3.37% as against the Sensexs 8.33% rise.

The large-cap company has equity capital of Rs 37.70 crore. Face value per share is Rs 2.

Alembic Pharmaceuticals announced that it has received final approvals from the United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Olmesartan Medoxomil Tablets, 5mg, 20mg and 40mg and Olmesartan Medoxomil with Hydrochlorothiazide Tablets 20/12.5 mg, 40/12.5 mg and 40/25 mg.

The approved ANDAs are therapeutically equivalent to the reference listed drug products (RLDs) Benicar Tablets 5mg, 20mg and 40 mg and Benicar HCT Tablets, 20/12.5 mg, 40/12.5 mg and 40/25 mg of Daiichi Sankyo Inc. The approved ANDAs are indicated for the treatment of hypertension.

Benicar and Benicar HCT had an estimated annual market size of $1.8 billion in US for twelve months ended 31 December 2016, according to IMS.

Alembic now has a total of 55 ANDA approvals (49 final approvals and 6 tentative approvals) from the USFDA.

On a consolidated basis, net profit of Alembic Pharmaceuticals declined 67.8% to Rs 86.55 crore on 15.9% decline in net sales to Rs 769.86 crore in Q3 December 2016 over Q3 December 2015.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, manufactures and markets generic pharmaceutical products all over the world.

Powered by Capital Market - Live News

Volumes jump at Welspun Corp counter
Apr 25,2017

Welspun Corp clocked volume of 69.18 lakh shares by 13:49 IST on BSE, a 165.87-times surge over two-week average daily volume of 42,000 shares. The stock surged 6.04% at Rs 86.85.

Essar Shipping notched up volume of 31.46 lakh shares, a 73.2-fold surge over two-week average daily volume of 43,000 shares. The stock jumped 9.98% at Rs 33.60.

Kalpataru Power Transmission saw volume of 3.02 lakh shares, a 32.86-fold surge over two-week average daily volume of 9,000 shares. The stock rose 0.86% at Rs 351.35.

Indian Bank clocked volume of 15.12 lakh shares, a 15.16-fold surge over two-week average daily volume of 1 lakh shares. The stock spurted 9.01% at Rs 310.85.

Biocon saw volume of 3 lakh shares, a 8.81 -fold rise over two-week average daily volume of 34,000 shares. The stock surged 9.95% at Rs 1,172.

Powered by Capital Market - Live News

Biocon leads gainers in BSEs A group
Apr 25,2017

Biocon jumped 10.47% at Rs 1,177.45 at 13:45 IST on BSE after the company said that its board of directors will consider bonus issue of shares at a meeting scheduled on Thursday, 27 April 2017. The announcement was made after market hours yesterday, 24 April 2017. The stock topped the gainers in A group. On the BSE, 3.33 lakh shares were traded on the counter so far as against the average daily volumes of 34,000 shares in the past two weeks.

Indian Bank surged 9.21% at Rs 311.40. The stock was the second biggest gainer in A group. On the BSE, 15.2 lakh shares were traded on the counter so far as against the average daily volumes of 1 lakh shares in the past two weeks.

Welspun Corp gained 6.11% at Rs 86.90. The stock was the third biggest gainer in A group. On the BSE, 69.18 lakh shares were traded on the counter so far as against the average daily volumes of 42,000 shares in the past two weeks.

Bayer Cropscience surged 5.79% at Rs 4,563.90. The stock was the fourth biggest gainer in A group. On the BSE, 7,244 shares were traded on the counter so far as against the average daily volumes of 7,595 shares in the past two weeks.

Delta Corp rose 5.75% at Rs 176.60. The stock was the fifth biggest gainer in A group. On the BSE, 15.89 lakh shares were traded on the counter so far as against the average daily volumes of 12.15 lakh shares in the past two weeks.

Powered by Capital Market - Live News

Eros drops as promoter pares stake
Apr 25,2017

Meanwhile, the S&P BSE Sensex was up 219.28 points or 0.74% at 29,875.12. The S&P BSE Small-Cap was up 135.48 points or 0.89% at 15,426.74.

On the BSE, 99,000 shares were traded on the counter so far as against the average daily volumes of 1.80 lakh shares in the past one quarter. The stock had hit a high of Rs 238.50 and a low of Rs 232.60 so far during the day.

The stock had hit a 52-week high of Rs 308.40 on 28 March 2017 and a 52-week low of Rs 150.15 on 22 November 2016. It had underperformed the market over the past one month till 24 April 2017, sliding 11.6% compared with the Sensexs 0.8% rise. The scrip had, however, outperformed the market over the past one quarter, gaining 37.73% as against the Sensexs 8.33% rise.

Eros Worldwide FZ LLC sold 5.72 lakh shares of Eros International Media at Rs 240.73 per share in a bulk deal on the NSE yesterday, 24 April 2017.

Eros Worldwide FZ LLC held 50.21% stake in Eros International Media end March 2017.

On consolidated basis, Eros International Medias net profit rose 149.6% to Rs 101.88 crore on 1% decline in net sales to Rs 332.12 crore in Q3 December 2016 over Q3 December 2015.

Eros International Media operates in the Indian film entertainment industry. It acquires, co-produces and distributes Indian films across all available formats such as cinema, television and digital new media.

Powered by Capital Market - Live News

Jubilant Life gets healthier after receiving USFDA nod for drug
Apr 25,2017

The announcement was made during market hours today, 25 April 2017.

Meanwhile, the S&P BSE Sensex was up 185.93 points or 0.63% at 29,841.77.

On the BSE, 97,280 shares were traded on the counter so far as against the average daily volumes of 1.05 lakh shares in the past one quarter. The stock had hit a high of Rs 835.30 and a low of Rs 792.90 so far during the day.

The stock had hit a record high of Rs 879.10 on 12 April 2017 and a 52-week low of Rs 294.20 on 24 June 2016.

It had outperformed the market over the past one month till 24 April 2017, gaining 1.07% compared with the Sensexs 0.8% rise. The scrip had also outperformed the market over the past one quarter, advancing 13.83% as against the Sensexs 8.33% rise.

The large-cap company has equity capital of Rs 15.93 crore. Face value per share is Rs 1.

Jubilant Life Sciences announced that it has received Abbreviated New Drug Application (ANDA) final approval for Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg from the United States Food & Drug Administration (USFDA).

Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg is the generic version of Benicar of Daiichi Sankyo, which is used for the treatment of hypertension.

This is the second approval that the company has received from the USFDA during the current financial year. The company had a total of 73 ANDAs for oral solids filed in the US, of which 49 have been approved.

Jubilant Life Sciences consolidated net profit fell 2.6% to Rs 119.78 crore on 8.7% rise in net sales to Rs 1438.81 crore in Q3 December 2016 over Q3 December 2015.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in pharmaceuticals, life science ingredients and drug discovery solutions. The pharmaceuticals segment, through its wholly owned subsidiary Jubilant Pharma, is engaged in manufacture and supply of APIs, solid dosage formulations, radiopharmaceuticals, allergy therapy products and contract manufacturing of sterile and non-sterile products through 6 USFDA approved manufacturing facilities in India, USA and Canada.

The life science ingredients segment, is engaged in specialty intermediates, nutritional products and life science chemicals through 5 manufacturing facilities in India. The drug discovery solutions segment, provides proprietary in-house innovation & collaborative research and partnership for out-licensing through 3 world class research centres in India and USA.

Powered by Capital Market - Live News

Wendt (India) advances after good Q4 earnings
Apr 25,2017

The result was announced after market hours yesterday, 24 April 2017.

Meanwhile, the S&P BSE Sensex was up 190.47 points or 0.64% at 29,846.71.

On the BSE, 526 shares were traded on the counter so far as against the average daily volumes of 481 shares in the past two weeks. The stock had hit a high of Rs 2,360 and a low of Rs 2,300 so far during the day. The stock had hit a 52-week high of Rs 2,445 on 21 April 2017 and a 52-week low of Rs 1,666 on 26 December 2016.

Wendt (India)s board recommended a dividend of Rs 15 per share for the year ended March 2017.

Wendt (India) is a manufacturer of super abrasives, grinding, honing and special purpose machines and components.

Powered by Capital Market - Live News

IndusInd Bank nudges higher after opening new branch
Apr 25,2017

The announcement was made after market hours yesterday, 24 April 2017.

Meanwhile, the S&P BSE Sensex was up 191.31 points, or 0.65% to 29,847.15.

On the BSE, 3,721 shares were traded in the counter so far, compared with average daily volumes of 1.44 lakh shares in the past one quarter.

The stock had hit a high of Rs 1,444 and a low of Rs 1,435.20 so far during the day. The stock had hit a record high of Rs 1,444.55 on 13 April 2017. The stock had hit a 52-week low of Rs 965.65 on 21 April 2016.

It had outperformed the market over the past one month till 24 April 2017, gaining 3.19% compared with the Sensexs 0.8% rise. The scrip had also outperformed the market over the past one quarter, advancing 14.56% as against the Sensexs 8.33% rise.

The large-cap private sector bank has equity capital of Rs 598.21 crore. Face value per share is Rs 10.

Expanding presence across Jharkhand, IndusInd Bank recently inaugurated its third branch in Jamshedpur, the first planned industrial city of India. The branch is located at Mango, Jamshedpur.

With the inauguration of this branch, the bank now has 19 branches in Jharkhand.

Meanwhile, IndusInd Bank announced during market hours yesterday, 24 April 2017 that it recently inaugurated its first branch in Bhinder, known for its silver and cloth market. The branch is located at Rampole Darwaja, station road, Bhinder, Udaipur, Rajasthan. With the inauguration of this branch, the bank now has 94 branches in Rajasthan.

IndusInd Banks net profit rose 21.2% to Rs 751.61 crore on 22.4% increase in total income to Rs 5041.31 crore in Q4 March 2017 over Q4 March 2016.

Induslnd Bank is a private sector bank and caters to the needs of both consumer and corporate customers.

Powered by Capital Market - Live News

Lumax declines on profit booking
Apr 25,2017

Meanwhile, the S&P BSE Sensex was up 179.86 points or 0.61% at 29,835.70. The S&P BSE Small-Cap index was up 117.01 points or 0.77% at 15,408.27.

On the BSE, 2,485 shares were traded on the counter so far as against the average daily volumes of 4,251 shares in the past one quarter. The stock had hit a high of Rs 1,540 and a low of Rs 1,481.15 so far during the day.

The stock had hit a record high of Rs 1,561.55 on 24 April 2017 and a 52-week low of Rs 430.50 on 4 May 2016. It had outperformed the market over the past one month till 24 April 2017, surging 11.82% compared with the Sensexs 0.8% rise. The scrip had also outperformed the market over the past one quarter, gaining 38.1% as against the Sensexs 8.33% rise.

Shares of Lumax Industries had rallied 12.2% to settle at Rs 1,522.65 in a single trading session yesterday, 24 April 2017, after the company said after market hours on 21 April 2017 that it has received a new customer order.

Lumax Industries said it has received order to supply new age headlamps and rear lamps for the new generation Maruti Suzuki Swift that commences production later this year at carmakers Gujarat facility in Mehsana district. The order will be fulfilled from the Sanand plant.

Lumax has done a capex of about Rs 120 crore, at Sanand, which is expected to commence operations from November 2017. The capex has been funded through internal accruals.

Going forward, the plant is expected to cater to the needs of TATA Tigor at Sanand as well as HMSIs existing models at Gujarat. The facility will have a capacity of about 3 lakh car-sets annually. The plant is expected to be operational at its full capacity by FY19-20.

On consolidated basis, Lumax Industries net profit rose 67.7% to Rs 17.04 crore on 3.4% decline in net sales to Rs 297.15 crore in Q3 December 2016 over Q3 December 2015.

Lumax Industries is one the leading players in the automotive lighting industry in India.

Powered by Capital Market - Live News

Pokarna jumps on stock split proposal
Apr 25,2017

The announcement was made after market hours yesterday, 24 April 2017.

Meanwhile, the S&P BSE Sensex was up 162.70 points or 0.55% at 29,818.54.

On the BSE, 9,987 shares were traded on the counter so far as against the average daily volumes of 4,457 shares in the past one quarter. The stock had hit a high of Rs 1,505 so far during the day, which is a 52-week high. The stock hit a low of Rs 1,470 so far during the day. The stock had hit a 52-week low of Rs 710 on 24 August 2016.

On consolidated basis, Pokarnas net profit fell 16.6% to Rs 17.36 crore on 5.5% decline in net sales to Rs 91.91 crore in Q3 December 2016 over Q3 December 2015.

Pokarna processes granite at its manufacturing facilities with raw material majorly sourced from its own quarries. The company also operates in quartz business.

Powered by Capital Market - Live News

Biocon scales fresh high after plans of bonus issue
Apr 25,2017

The announcement was made after market hours yesterday, 24 April 2017.

Meanwhile, the S&P BSE Sensex was up 143.16 points, or 0.48% to 29,799.

High volumes were witnessed on the counter. On the BSE, 1.73 lakh shares were traded in the counter so far, compared with average daily volumes of 50,291 shares in the past one quarter.

The stock had hit a high of Rs 1,168 in intraday trade, which is also a record high for the counter. The stock had hit a low of Rs 1,103 so far during the day. The stock had hit a 52-week low of Rs 547.15 on 21 April 2016.

The large-cap bio-pharmaceutical company has equity capital of Rs 100 crore. Face value per share is Rs 5.

On a consolidated basis, net profit of Biocon rose 64.6% to Rs 171.30 crore on 29.6% rise in net sales to Rs 1022.50 crore in Q3 December 2016 over Q3 December 2015.

The company will announce its Q4 results on 27 April 2017.

Biocon is Indias largest and fully-integrated, innovation-led biopharmaceutical company.

Powered by Capital Market - Live News

Good Q4 results boosts RIL counter
Apr 25,2017

The result was announced after market hours yesterday, 24 April 2017.

Meanwhile, the S&P BSE Sensex was up 130.39 points or 0.48% at 29,798.80.

On the BSE, 2.09 lakh shares were traded on the counter so far as against the average daily volumes of 2.01 crore shares in the past one quarter. The stock had hit a high of Rs 1,465 in intraday trade, which is its highest level since 17 January 2008. The stock hit a low of Rs 1,441.05 so far during the day. The stock had hit a 52-week low of Rs 925.70 on 23 May 2016.

The large-cap company has equity capital of Rs 3251.33 crore. Face value per share is Rs 10.

Reliance Industries (RIL) increase in revenue in Q4 was primarily on account of increase in prices of refining and petrochemical products on the back of higher oil prices. Turnover was also boosted by robust growth in retail business. Gross refining margin (GRM) rose to $11.5 per barrel in Q4 March 2017 from $10.8 per barrel each in Q3 December 2016 and in Q4 March 2016.

Earning per share (EPS) excluding exceptional items rose to Rs 27.3 in Q4 March 2017 compared with Rs 25.5 in Q3 December 2016 and Rs 23.4 in Q4 March 2016.

Outstanding debt as on 31 March 2017 was Rs 196601 crore ($30.3 billion) compared to Rs 180665 crore as on 31 March 2016. Cash and cash equivalents as on 31st March 2017 were at Rs 77226 crore ($11.9 billion) compared to Rs 89969 crore as on 31 March 2016.

The board of directors recommended a dividend of Rs 11 per share for the financial year ended 31 March 2017.

Meanwhile, RIL said, Reliance Jio Infocomm, a subsidiary of RIL crossed 50 million subscribers in just 83 days, and 100 million in 170 days, adding at an average rate of 6 lakh subscribers per day. Jio continues its rapid ramp-up of subscriber base and as of 31 March 2017, there were 10.89 crore subscribers on the network.

Reliance Industries (RIL) is Indias largest private sector company. RILs activities span hydrocarbon exploration and production, petroleum refining and marketing, petrochemicals, retail and telecommunications.

Powered by Capital Market - Live News